Larvol Delta - Claritys-USbased-Cu64-SARbisPSMA-trial-in-prostate-cancer-opens-for-recruitment

64/67Cu SAR-bisPSMA theranostic - Clarity Pharma

https://www.prnewswire.com/news-releases/claritys-us-based-cu-64-sar-bispsma-trial-in-prostate-cancer-opens-for-recruitment-301511410.html

Mar 28, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next